Population Pharmacokinetics of Imatinib in CML Patients in Iran

NCT02146846 · clinicaltrials.gov ↗

TERMINATED

Status

170

Enrollment

OTHER

Sponsor class

Conditions

Chronic Myelogenous Leukemia

Interventions

DRUG: Imatinib

Sponsor

Kerman University of Medical Sciences